Declining estrogen during menopause triggers a measurable rise in inflammatory molecules throughout the body, and reducing that inflammation involves a combination of dietary changes, exercise, sleep protection, and, for some women, specific choices about hormone therapy. Research shows that levels of pro-inflammatory cytokines like IL-6 and TNF-α climb as estradiol falls during perimenopause, and that this shift is not just a background nuisance but a driver of cardiovascular risk, bone loss, cognitive changes, and joint pain. The good news is that most of the strategies that help are accessible and well-supported by evidence.
Why Menopause Makes Inflammation Worse
Estrogen does far more than regulate reproductive cycles. It acts as a brake on several arms of the immune system, keeping certain inflammatory pathways in check. When estrogen levels drop during perimenopause and menopause, that brake loosens. Studies comparing postmenopausal women to premenopausal controls find significantly higher blood levels of IL-1β, IL-8, and TNF-α after menopause, whether the transition happened naturally or through surgery.1PubMed Central. Proinflammatory and anti-inflammatory cytokine changes related to menopause A longitudinal study tracking perimenopausal women over 12 months found that as estradiol declined, IL-6 and TNF-α rose in tandem, while premenopausal controls stayed stable.2PubMed. Estradiol reduction during perimenopause is associated with lower BDNF, elevated inflammation, hippocampal loss, and cognitive decline
One of the specific mechanisms involves estrogen receptor beta, which normally helps regulate a key part of the innate immune response called the inflammasome. When estrogen drops, this regulation weakens, and the inflammasome becomes more active. The perimenopause has been described in recent reviews as a “systemic inflammatory phase” for this reason, one that sets the stage for downstream problems in the brain, the cardiovascular system, and the skeleton.3PubMed Central. The peri-menopause in a woman’s life: a systemic inflammatory phase that enables later neurodegenerative disease
The Visceral Fat Problem
If you’ve noticed weight gathering around your midsection during the menopausal transition, that shift is not cosmetic. Visceral fat, the deep abdominal fat surrounding your organs, is metabolically active tissue that pumps out inflammatory signals. A prospective study tracking women across the menopausal transition found that increases in intra-abdominal fat correlated strongly with rises in C-reactive protein (CRP), a widely used marker of systemic inflammation. The link held even after accounting for subcutaneous fat, meaning it was the deep visceral fat specifically driving the inflammatory changes.4The Journal of Clinical Endocrinology & Metabolism. Adipokines, Inflammation, and Visceral Adiposity across the Menopausal Transition: A Prospective Study
Animal research has helped clarify why. In estrogen-deficient mice, immune cells in visceral fat shift toward a pro-inflammatory state, and estrogen replacement reverses this pattern. When estrogen is absent, a type of aging-associated immune cell called senescence-related T cells accumulates in visceral fat, mimicking the inflammatory profile normally seen in males. Adding estradiol back abolished this accumulation.5PubMed. Estrogen contributes to the sex difference in the occurrence of senescence-related T cells during the development of visceral adipose tissue inflammation The practical takeaway is that anything you do to limit visceral fat gain during menopause, whether through diet, exercise, or both, is simultaneously an anti-inflammatory strategy.
What to Eat and When to Eat It
The Mediterranean diet has the strongest evidence base for reducing inflammation in menopausal women specifically. A systematic review of Mediterranean diet interventions in this population found a significant drop in CRP, with a mean reduction of about 1.2 mg/L, a clinically meaningful change given that CRP levels above 3 mg/L are considered high cardiovascular risk.6PubMed Central. Systematic review of mediterranean diet interventions in menopausal women The diet emphasizes vegetables, fruits, whole grains, legumes, nuts, olive oil, and fish while limiting red meat and processed foods. You don’t need to follow it rigidly to benefit; even partial adoption moves the needle.
Soy foods and other sources of isoflavones deserve special mention. Isoflavones are plant compounds that have structural similarity to estrogen, and research has highlighted their anti-inflammatory and antioxidant properties, with increasing evidence that they help prevent chronic diseases in which inflammation plays a key role.7PubMed Central. Isoflavones: Anti-Inflammatory Benefit and Possible Caveats Tofu, tempeh, edamame, and miso are all good sources. The amounts typically consumed in traditional Asian diets appear beneficial, though the evidence on high-dose isoflavone supplements is less clear-cut.
Intermittent fasting has also drawn research attention. A randomized controlled trial in postmenopausal, overweight and obese women with rheumatoid arthritis found that intermittent fasting significantly lowered markers of oxidative stress and inflammation compared to a control group, while boosting levels of catalase, a protective antioxidant enzyme.8Scientific Reports. The effects of intermittent fasting on antioxidant and inflammatory markers and liver enzymes in postmenopausal, overweight and obese women with rheumatoid arthritis: a randomized controlled trial An animal study suggests that time-restricted feeding aligned with natural circadian rhythms can prevent the metabolic deterioration seen in estrogen-deficient states, including elevated white blood cell counts.9PubMed. Circadian Rhythm-Aligned Time-Restricted Feeding Prevents Ovariectomy-Induced Fat Gain, Insulin Resistance, and Osteosarcopenia in Rats If you’re interested in intermittent fasting, the approach of eating within an 8-to-10-hour window during daytime hours and avoiding late-night meals is the version best supported by current data.
Your Gut Microbiome Is Part of the Equation
The gut microbiome and estrogen have a two-way relationship. A collection of gut bacteria known informally as the “estrobolome” helps metabolize estrogen in the digestive tract, influencing how much circulating estrogen remains available. When gut microbial diversity drops during perimenopause, the balance shifts. Reduced diversity and altered ratios of major bacterial groups have been linked to higher levels of inflammatory biomarkers during the menopausal transition.10PubMed Central. Diet, the Gut Microbiome, and Estrogen Physiology: A Review in Menopausal Health and Interventions
Supporting gut health during menopause means eating plenty of fiber-rich foods like vegetables, legumes, and whole grains, which feed beneficial bacteria. Fermented foods such as yogurt, kefir, sauerkraut, and kimchi supply live microbes directly. The Mediterranean diet, which is already the best-supported anti-inflammatory eating pattern for menopausal women, also happens to be one of the best diets for gut microbial diversity. This is probably not a coincidence: a healthy gut that processes estrogen efficiently and maintains microbial diversity appears to be one of the pathways through which diet reduces systemic inflammation.
Exercise That Targets Inflammation
A meta-analysis pooling data from multiple trials in postmenopausal women found that exercise training significantly reduced IL-6, TNF-α, and CRP, the three inflammatory markers most commonly elevated after menopause. All three types of exercise studied, aerobic, resistance, and combined, produced significant reductions.11PubMed. The impact of exercise training on inflammatory markers in postmenopausal women: A systemic review and meta-analysis So you don’t have to choose between cardio and weights for anti-inflammatory benefit; both work.
That said, head-to-head comparisons suggest aerobic exercise may have a slight edge. A trial comparing aerobic and resistance training in obese postmenopausal women found that while both groups had significant drops in TNF-α, IL-6, CRP, and BMI, the aerobic group showed larger improvements in inflammatory markers and quality-of-life scores.12PubMed Central. Impact of aerobic versus resisted exercise training on systemic inflammation biomarkers and quality of Life among obese post-menopausal women Brisk walking, cycling, swimming, and dancing all count as aerobic exercise. The ideal routine probably combines aerobic activity with some resistance training, since resistance exercise independently benefits bone density, a particular concern during menopause.
Why Sleep Matters More Than You Think
Sleep disruption is one of the hallmark complaints of menopause, driven by night sweats, hormonal shifts in brain chemistry, and sometimes mood changes. What many women don’t realize is that poor sleep is directly inflammatory. An experimental study simulating the sleep fragmentation typical of menopause found that disrupted sleep raised bedtime cortisol levels by about 27% and slashed the normal morning cortisol awakening response by roughly 57%.13The Journal of Clinical Endocrinology & Metabolism. Effects of Sleep Fragmentation and Estradiol Decline on Cortisol in a Human Experimental Model of Menopause Cortisol, when chronically elevated at night and flattened in the morning, promotes inflammation and metabolic dysfunction.
Protecting sleep is therefore a front-line anti-inflammatory strategy during menopause. Practical steps include keeping the bedroom cool (a particular help for night sweats), maintaining consistent sleep and wake times, limiting caffeine after midday, and minimizing screen exposure in the hour before bed. If hot flashes are the primary sleep disruptor, treating those directly, whether with hormone therapy, certain non-hormonal prescription options, or layered bedding that can be kicked off quickly, may do more for inflammation than any supplement.
Mind-body practices like yoga, tai chi, and meditation have also shown promise. A meta-analysis of randomized controlled trials found that these approaches can reduce sleep disturbances, depression, and anxiety in menopausal women, and the proposed mechanisms include reduced overactivity of the stress-hormone axis and decreased pro-inflammatory cytokines.14Frontiers in Public Health. Mind–body therapies for sleep disturbances, depression, and anxiety in menopausal women: a systematic review and meta-analysis of randomized controlled trials
Hormone Therapy and the Route-of-Delivery Difference
Hormone therapy (HT) replaces some of the estrogen lost during menopause and can reduce inflammation, but here the details matter a great deal. Research has found a striking difference between how estrogen is delivered. Oral estrogen, which passes through the liver before entering the general circulation, causes a large spike in CRP. One study found that eight weeks of oral conjugated estrogens more than doubled CRP while also reducing IGF-1, an anti-inflammatory growth factor. Transdermal estrogen (patches, gels, or sprays), by contrast, had no effect on CRP or IGF-1 in the same women.15PubMed. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women
A separate study found that oral estrogen raised serum amyloid A, another inflammatory protein produced by the liver, and increased the inflammatory content of HDL cholesterol particles. Transdermal estrogen actually reduced both.16PubMed. Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women A third study measuring a broader panel of markers confirmed the pattern: oral estrogen caused a 192% median increase in CRP, while transdermal estradiol had minimal effects on CRP and other inflammatory or hepatic markers.17The Journal of Clinical Endocrinology & Metabolism. A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women
If you’re considering hormone therapy partly for its anti-inflammatory benefits, the evidence strongly favors a transdermal route. This is a conversation to have with your prescriber, since oral formulations remain more commonly dispensed in many settings simply out of habit and convenience.
Vitamin D and Omega-3 Supplements
Vitamin D supplementation has shown promise specifically in postmenopausal women. A meta-analysis of randomized controlled trials found that vitamin D supplementation significantly reduced CRP, with an average drop of about 0.65 mg/L. The effect was larger in studies lasting longer than three months.18PubMed Central. The Effects of Vitamin D Supplementation on C-Reactive Protein and Systolic and Diastolic Blood Pressure in Postmenopausal Women: A Meta-Analysis and Systematic Review of Randomized Controlled Trials Many postmenopausal women are vitamin D insufficient, particularly those at higher latitudes or with limited sun exposure. Getting your level tested before supplementing makes sense, because the anti-inflammatory benefit is most apparent when correcting a deficiency.
Omega-3 fatty acids, found in fatty fish and in EPA/DHA supplements, are established anti-inflammatory agents. But there’s an interesting wrinkle for postmenopausal women. A crossover study comparing postmenopausal women and men found that women produced lower levels of the anti-inflammatory lipid mediators derived from EPA and DHA, especially after supplementation. This suggests that postmenopausal women may need omega-3 supplementation more than age-matched men, but may also get somewhat less resolution of inflammation per gram consumed.19PubMed Central. Sex differences in lipid mediators derived from omega-3 fatty acids in older individuals with low-grade chronic inflammation Eating fatty fish two to three times a week, or supplementing with a combined EPA/DHA product, is still a reasonable anti-inflammatory strategy, but postmenopausal women should not expect the same magnitude of effect that research conducted primarily in men might suggest.
Bones, Joints, and Hidden Inflammation
Joint aches and stiffness are among the most common and least discussed symptoms of menopause. Estrogen normally helps regulate a molecule called RANKL, which controls how aggressively bone-resorbing cells do their work. When estrogen drops, RANKL expression increases, leading to faster bone breakdown.20PubMed Central. Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells This process is not just about bone density numbers on a scan; it involves active inflammatory signaling.
T cells play a surprising role here. Research has shown that estrogen deficiency ramps up T-cell production of TNF-α, and that this TNF-α amplifies the activity of bone-resorbing cells. In T-cell-deficient mice, estrogen loss failed to cause bone loss altogether, confirming that the immune system’s inflammatory response is an essential part of how menopause damages bone.21PubMed Central. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha This means that the same anti-inflammatory strategies that protect your cardiovascular system, exercise, diet, adequate vitamin D, and possibly hormone therapy, are also protecting your skeleton. Menopausal joint pain is not “just aging”; it’s inflammation that can be addressed.
Cardiovascular and Vascular Effects
The rise in heart disease risk after menopause is closely tied to vascular inflammation. Endothelial function, the ability of blood vessel walls to relax and dilate properly, declines across the menopausal transition, and this decline tracks with falling estradiol and rising oxidative stress.22PubMed Central. Decline in endothelial function across the menopause transition in healthy women is related to decreased estradiol and increased oxidative stress Vasomotor symptoms like hot flashes and night sweats are not just an annoyance; they have been linked to elevated blood pressure and increased cardiovascular risk, likely through autonomic nervous system dysregulation.23American Journal of Physiology-Heart and Circulatory Physiology. Vasomotor symptoms of menopause, autonomic dysfunction, and cardiovascular disease
There’s an important caveat about timing. Animal research has found that estrogen’s ability to dampen vascular inflammation is age-dependent: it works well in younger blood vessels but loses effectiveness in aged ones, because the estrogen receptors on immune cells diminish with age.24PubMed Central. Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors This helps explain why starting hormone therapy many years after menopause does not provide the same cardiovascular protection as starting it near the transition. For vascular inflammation specifically, the window of opportunity for hormonal intervention appears to narrow with time.
Oral Health and Gum Inflammation
An area that catches many women off guard is how much menopause affects the mouth. Estrogen deficiency correlates with increased susceptibility to periodontal disease, characterized by greater attachment loss between teeth and gums and more breakdown of the bone supporting teeth.25PubMed Central. The impact of estrogen on periodontal tissue integrity and inflammation-a mini review Research has also found a connection between visceral fat accumulation in estrogen-deficient states and worsening periodontitis, with macrophages in fat tissue sending pro-inflammatory signals that amplify gum disease. In animal models, removing visceral fat actually alleviated periodontitis.26PubMed Central. Adipose Tissue Macrophages as Initiators of Exacerbated Periodontitis in Estrogen-Deficient Environments via the Amplifier Extracellular Vesicles
If your gums have started bleeding more or your dentist has noted deeper pockets during cleanings, menopause-related inflammation is a plausible contributor. More frequent dental cleanings, meticulous brushing and flossing, and the systemic anti-inflammatory approaches described in this article can all help. Your dental health and your metabolic health are more connected than most people realize.
What Menopause-Related Inflammation Does to Skin
The skin is a visible barometer of the inflammatory and collagen-related changes happening throughout the body. After menopause, skin collagen declines at an average rate of about 2.1% per year, and overall skin thickness drops by roughly 1.1% per year during the first two decades after the transition. These changes involve both type I collagen, which gives skin its strength, and type III collagen, which gives it elasticity.27PubMed Central. Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement While this is often framed as a cosmetic issue, the underlying process reflects the same inflammatory and estrogen-deficient environment affecting every other organ. Inflammation accelerates the breakdown of the skin’s structural scaffolding, and oxidative stress compounds the damage.
Anti-inflammatory strategies that benefit your cardiovascular system and joints, including a diet rich in antioxidants, adequate omega-3 intake, sun protection, and good sleep, also slow these skin changes. Topical retinoids and sunscreen are the most evidence-based external interventions, but addressing systemic inflammation from the inside gives the skin a better foundation to maintain itself.
The Brain Connection
Neuroinflammation, inflammation specifically within the brain, is a growing area of concern in menopause research. Estrogen normally helps steer certain immune cells in the brain toward a protective state, and when estrogen drops, those cells shift toward a more inflammatory one. Research has shown that progression of neuroinflammation-related neurodegeneration is higher in menopausal women, likely because low circulating estrogen allows brain immune cells to become more reactive.28PubMed. Menopause triggers microglia-associated neuroinflammation in Parkinson’s disease The same longitudinal study that tracked rising IL-6 and TNF-α during perimenopause also found associated reductions in hippocampal volume and memory performance, connecting systemic inflammation directly to brain structure and function.2PubMed. Estradiol reduction during perimenopause is associated with lower BDNF, elevated inflammation, hippocampal loss, and cognitive decline
The “brain fog” many women describe during perimenopause is not imaginary, and it is not an inevitable part of aging. It has a biological basis in inflammation and reduced neurotrophic support. Exercise is particularly relevant here, given its dual role in reducing systemic inflammatory markers and increasing brain-derived neurotrophic factor, the very molecule that declines as estradiol drops. Aerobic exercise, a Mediterranean-style diet, good sleep, stress management, and, where appropriate, timely hormone therapy represent a comprehensive approach to protecting the brain during this transition.